Keywords:
IL17A (G-197A), риск формирования, носительство, тяжесть течения, апластическая анемия.References
Dai Z. M. et al. Role of IL-17A rs2275913 and IL-17F rs763780 polymorphisms in risk of cancer development: an updated meta-analysis // Scientific report. – 2016. – Т. 6. – №. 1. – С. 20439.
Gaman A., Gaman G., Bold A. Acquired aplastic anemia: correlation between etiology, pathophysiology, bone marrow histology and prognosis factors //Rom J Morphol Embryol. – 2009. – Т. 50. – №. 4. – С. 669-674.
Giudice V., Selleri C. Aplastic anemia: pathophysiology //Seminars in Hematology. – WB Saunders, 2022. – Т. 59. – №. 1. – С. 13-20.
Kadia T. M. et al. Phase I clinical trial of CK0801 (cord blood regulatory T cells) in patients with bone marrow failure syndrome (BMF) including aplastic anemia, myelodysplasia and myelofibrosis //Blood. – 2019. – Т. 134. – С. 1221.
Li H. et al. In patients with chronic aplastic anemia, bone marrow–derived MSCs regulate the Treg/Th17 balance by influencing the Notch/RBP-J/FOXP3/RORγt pathway //Scientific reports. – 2017. – Т. 7. – №. 1. – С. 42488.
Ni R. et al. A mouse model of irradiation and spleen-thymus lymphocyte infusion induced aplastic anemia //Hematology. – 2022. – Т. 27. – №. 1. – С. 932-945.
Wang L., Liu H. Pathogenesis of aplastic anemia //Hematology. – 2019. – Т. 24. – №. 1. – С. 559-566.
Yan L, Fu R, Liu H, Wang H, Liu C, Wang T, Qi W, Guan J, Li L, Shao Z. Abnormal quantity and function of regulatory T cells in peripheral blood of patients with severe aplastic anemia.
Zhang J. et al. Basal level of Th17 immune response is not enhanced in aplastic amemia //Cyto-kine. – 2015. – Т. 74. – №. 2. – С. 331-334.
Zhao J. et al. Human gingiva tissue-derived MSC ameliorates immune-mediated bone marrow failure of aplastic anemia via suppression of Th1 and Th17 cells and enhancement of CD4+ Foxp3+ regula-tory T cells differentiation //American journal of translational research. – 2019. – Т. 11. – №. 12. – С. 7627.